valproic acid has been researched along with Retinal Diseases in 7 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Retinal Diseases: Diseases involving the RETINA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vigabatrin acts as an inhibitor of gamma-aminobutyric acid (GABA) transaminase." | 1.30 | Outer retinal dysfunction in patients treated with vigabatrin. ( Arndt, CF; Defoort-Dhellemmes, S; Derambure, P; Hache, JC, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iizuka, N | 1 |
| Morita, A | 1 |
| Kawano, C | 1 |
| Mori, A | 1 |
| Sakamoto, K | 1 |
| Kuroyama, M | 1 |
| Ishii, K | 1 |
| Nakahara, T | 1 |
| Zhang, Z | 1 |
| Qin, X | 1 |
| Tong, N | 1 |
| Zhao, X | 1 |
| Gong, Y | 1 |
| Shi, Y | 1 |
| Wu, X | 1 |
| Zhang, ZZ | 1 |
| Wu, XW | 1 |
| Gong, YY | 1 |
| Zhang, W | 1 |
| Yin, LL | 1 |
| Lobefalo, L | 1 |
| Rapinese, M | 1 |
| Altobelli, E | 1 |
| Di Mascio, R | 1 |
| Lattanzi, D | 1 |
| Gallenga, PE | 1 |
| Chiarelli, F | 1 |
| Verrotti, A | 1 |
| Nizamie, SH | 1 |
| Chatterjee, S | 1 |
| Arndt, CF | 1 |
| Derambure, P | 1 |
| Defoort-Dhellemmes, S | 1 |
| Hache, JC | 1 |
| Ozkul, Y | 1 |
| Gurler, B | 1 |
| Uckardes, A | 1 |
| Bozlar, S | 1 |
7 other studies available for valproic acid and Retinal Diseases
| Article | Year |
|---|---|
Anti-angiogenic effects of valproic acid in a mouse model of oxygen-induced retinopathy.
Topics: Angiogenesis Inhibitors; Animals; Disease Models, Animal; Mice; Neovascularization, Pathologic; Oxyg | 2018 |
Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation.
Topics: Acetylation; Animals; Apoptosis; Apoptotic Protease-Activating Factor 1; Axons; Caspase 3; Cytochrom | 2012 |
[Protective effect of valproic acid on ischemia-reperfusion induced injury in retina of rat].
Topics: Animals; bcl-2-Associated X Protein; HSP70 Heat-Shock Proteins; Male; Proto-Oncogene Proteins c-bcl- | 2012 |
Retinal nerve fiber layer and macular thickness in adolescents with epilepsy treated with valproate and carbamazepine.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Color Vision Defects; Epilepsy; Female; Follow-Up | 2006 |
Affective psychosis in Eales' disease and response to sodium valproate.
Topics: Adult; Affective Disorders, Psychotic; Combined Modality Therapy; Electroconvulsive Therapy; Humans; | 1994 |
Outer retinal dysfunction in patients treated with vigabatrin.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Child; Electrooculography; Electroretinography; Epilepsies | 1999 |
Visual functions in epilepsy patients on valproate monotherapy.
Topics: Adolescent; Adult; Anticonvulsants; Electroretinography; Epilepsy; Female; Humans; Male; Reference V | 2002 |